MARINA GOZHA: Open Payments
NPI 1952904872 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,438 in 85 payments from 14 companies in 2025. Trend: 2023 $1,030 · 2024 $1,545 · 2025 $1,438
Food & beverage: $1,438
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 22 | $379 |
| Janssen Pharmaceuticals, Inc | 11 | $216 |
| ABBVIE INC. | 20 | $184 |
| Alkermes, Inc. | 6 | $118 |
| Otsuka America Pharmaceutical, Inc. | 4 | $93 |
| Neurocrine BioSciences, Inc. | 4 | $90 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| Neos Therapeutics, LP | 4 | $67 |
| Supernus Pharmaceuticals, Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
Products named: COBENFY, VRAYLAR, SPRAVATO, ARISTADA, INGREZZA, REXULTI, Adzenys XR-ODT, Qelbree.
Industry payments across VA — which companies pay providers there.
